US Drug Recall Register
Class II · Moderate risk Terminated Initiated May 25, 2012 (14 years ago)

Acetic Acid

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.

What was recalled

ACETIC ACID, IRRIGATION 3% SOLUTION 500 ML (1 PRODUCT)

Recalling firm
Franck's Lab Inc., d.b.a. Franck's Compounding Lab
Origin
FL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1448-2012

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Acetic recalls

See all
Class III · Low risk Completed

Hydrocortisone 1% & Acetic Acid 2% Otic Solution

Reason Failed Impurities/Degradation Specifications: Out-of-specification results obtained for related impurities and slightly lower than the established level of the Hydrocortisone Assay obtained during stability testing.

Taro Pharmaceuticals U.S.A., Inc. NDC 51672-3007-01 D-0633-2024
Class III · Low risk Terminated

Hydrocortisone 1% and Acetic Acid 2% Otic Solution USP

Reason Failed Impurities/Degradation Specifications:Out-of-Specification result for Hydrocortisone related impurity and slightly lower than the established level of the Hydrocortisone Assay obtained during stability testing.

Taro Pharmaceuticals Inc. NDC 51672-3007-1 D-0089-2024
Class II · Moderate risk Ongoing

Acetic Acid Otic Solution

Reason CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Akorn, Inc. D-0781-2023
Class II · Moderate risk Terminated

Hydrocortisone and Acetic Acid Otic Solution

Reason Subpotent Drug: Low Out of specification (OOS) assay results for the hydrocortisone portion of this product.

Akorn Inc NDC 50383-901-10 D-0839-2020